See you next year in Seattle!
Collaboration Allows Portola to Advance Product Candidates Outside of Core Focus
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
SkQ1 is the first mitochondria-targeted antioxidant to reach clinical phase of development for an ophthalmic indication